Literature DB >> 19406586

Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume.

Min-Hua Wang1, Yuan Ji, Zhao-Chong Zeng, Zhao-You Tang, Jia Fan, Jian Zhou, Meng-Su Zeng, Ai-Hong Bi, Yun-Shan Tan.   

Abstract

PURPOSE: To evaluate the degree of invasion of hepatocellular carcinoma (HCC) microscopically that will provide a potential application for gross tumor volume to clinical tumor volume (GTV-to-CTV) expansion. METHODS AND MATERIALS: From January 2002 to January 2006, 149 HCC patients were selected from those who had undergone surgical resection. Pathology slides and clinical data of all patients were reviewed, including platelet counts, serum alpha-fetoprotein (AFP) levels, degree of liver cirrhosis, tumor size, capsular status, portal vein invasion, TNM stage, and histologic tumor grade. The distance between the tumor margin (or fibrous capsule) and the invasive lesions was measured by senior pathologists.
RESULTS: Of these 149 patients, 79 (53.0%) patients presented with tumor microinvasion between 0.5 and 4 mm. This degree of microinvasion was inversely correlated with lower platelet counts and positively correlated with higher AFP levels, larger tumor sizes, portal vein invasion, and advanced TNM stage. Microinvasion distances less than or equal to 2 mm were found in 96.1% of patients (74/77) with tumor dimensions less than or equal to 5 cm and in 94.5% of patients (85/90) with AFP levels less than 400 microg/l.
CONCLUSIONS: Based on our study findings, GTV-to-CTV expansions of 4 mm for HCC are required to conceal the gross tumor and any microscopic disease with 100% accuracy. Tumor size and AFP levels are the simplest indicators for determining the GTV-to-CTV distance for HCC. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406586     DOI: 10.1016/j.ijrobp.2009.01.057

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

Review 1.  Imaging and image-guided radiation therapy in liver cancer.

Authors:  Kristy K Brock
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

Review 2.  Technical advances in external radiotherapy for hepatocellular carcinoma.

Authors:  Shin-Hyung Park; Jae-Chul Kim; Min Kyu Kang
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

3.  The Predictors of Microscopic Vessel Invasion Differ Between Primary Hepatocellular Carcinoma and Hepatocellular Carcinoma with a Treatment History.

Authors:  Yukiyasu Okamura; Teiichi Sugiura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

4.  Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines.

Authors:  Theodore S Hong; Walter R Bosch; Sunil Krishnan; Tae K Kim; Harvey J Mamon; Paul Shyn; Edgar Ben-Josef; Jinsil Seong; Michael G Haddock; Jason C Cheng; Mary U Feng; Kevin L Stephans; David Roberge; Christopher Crane; Laura A Dawson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-15       Impact factor: 7.038

5.  High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT.

Authors:  Jia-Zhou Hou; Zhao-Chong Zeng; Bin-Liang Wang; Ping Yang; Jian-Ying Zhang; Hui-Fang Mo
Journal:  Jpn J Clin Oncol       Date:  2016-01-21       Impact factor: 3.019

6.  Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology.

Authors:  Francesco Dionisi; Alessia Guarneri; Veronica Dell'Acqua; Mariacristina Leonardi; Rita Niespolo; Gabriella Macchia; Tiziana Comito; Maurizio Amichetti; Pierfrancesco Franco; Savino Cilla; Luciana Caravatta; Filippo Alongi; Giovanna Mantello
Journal:  Radiol Med       Date:  2016-06-02       Impact factor: 3.469

7.  Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting.

Authors:  Zhao-Chong Zeng; Jinsil Seong; Sang Min Yoon; Jason Chia-Hsien Cheng; Ka-On Lam; Ann-Shing Lee; Ada Law; Jian-Ying Zhang; Yong Hu
Journal:  Liver Cancer       Date:  2017-08-30       Impact factor: 11.740

8.  Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).

Authors:  Jian Zhou; Hui-Chuan Sun; Zheng Wang; Wen-Ming Cong; Jian-Hua Wang; Meng-Su Zeng; Jia-Mei Yang; Ping Bie; Lian-Xin Liu; Tian-Fu Wen; Guo-Hong Han; Mao-Qiang Wang; Rui-Bao Liu; Li-Gong Lu; Zheng-Gang Ren; Min-Shan Chen; Zhao-Chong Zeng; Ping Liang; Chang-Hong Liang; Min Chen; Fu-Hua Yan; Wen-Ping Wang; Yuan Ji; Wen-Wu Cheng; Chao-Liu Dai; Wei-Dong Jia; Ya-Ming Li; Ye-Xiong Li; Jun Liang; Tian-Shu Liu; Guo-Yue Lv; Yi-Lei Mao; Wei-Xin Ren; Hong-Cheng Shi; Wen-Tao Wang; Xiao-Ying Wang; Bao-Cai Xing; Jian-Ming Xu; Jian-Yong Yang; Ye-Fa Yang; Sheng-Long Ye; Zheng-Yu Yin; Bo-Heng Zhang; Shui-Jun Zhang; Wei-Ping Zhou; Ji-Ye Zhu; Rong Liu; Ying-Hong Shi; Yong-Sheng Xiao; Zhi Dai; Gao-Jun Teng; Jian-Qiang Cai; Wei-Lin Wang; Jia-Hong Dong; Qiang Li; Feng Shen; Shu-Kui Qin; Jia Fan
Journal:  Liver Cancer       Date:  2018-06-14       Impact factor: 11.740

9.  Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy.

Authors:  Weihu Wang; Xiaoli Feng; Tao Zhang; Jing Jin; Shulian Wang; Yueping Liu; Yongwen Song; Xinfan Liu; Zihao Yu; Yexiong Li
Journal:  Radiat Oncol       Date:  2010-08-23       Impact factor: 3.481

10.  Treatment outcomes of helical intensity-modulated radiotherapy for unresectable hepatocellular carcinoma.

Authors:  Moonkyoo Kong; Seong Eon Hong; Woo Suk Choi; Jinhyun Choi; Youngkyong Kim
Journal:  Gut Liver       Date:  2013-04-09       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.